Advances in Recombinant Lipases: Production, Engineering, Immobilization and Application in the Pharmaceutical Industry
Достижения в области рекомбинантных липаз: получение, инженерия, иммобилизация и применение в фармацевтической промышленности
2020-09-09
SCID: 54.1/mwnf2f9u
Discuss with AI
directed evolutionenzyme immobilizationpharmaceutical industryprotein engineeringrecombinant lipases
Figures from the paper
Abstract (AI)
Lipases are one of the most used enzymes in the pharmaceutical industry due to their efficiency in organic syntheses, mainly in the production of enantiopure drugs. From an industrial viewpoint, the selection of an efficient expression system and host for recombinant lipase production is highly important. The most used hosts are Escherichia coli and Komagataella phaffii (previously known as Pichia pastoris) and less often reported Bacillus and Aspergillus strains. The use of efficient expression systems to overproduce homologous or heterologous lipases often require the use of strong promoters and the co-expression of chaperones. Protein engineering techniques, including rational design and directed evolution, are the most reported strategies for improving lipase characteristics. Additionally, lipases can be immobilized in different supports that enable improved properties and enzyme reuse. Here, we review approaches for strain and protein engineering, immobilization and the application of lipases in the pharmaceutical industry.
Key Findings
1
Efficient recombinant lipase overproduction often requires strong promoters and co-expression of molecular chaperones.
2
Escherichia coli and Komagataella phaffii are the most commonly used hosts for recombinant lipase production, while Bacillus and Aspergillus are less frequently reported.
3
Immobilizing lipases on suitable supports can enhance their properties and enable enzyme reuse in pharmaceutical applications.
4
Lipases are widely used in pharmaceutical organic synthesis, particularly for producing enantiopure drugs.
5
Rational design and directed evolution are the principal protein-engineering strategies reported for improving lipase characteristics.
Research Object
Recombinant lipases used in the pharmaceutical industry
Research Subject
Production, protein engineering, immobilization, and pharmaceutical applications of lipases, including improvement of their properties and reuse
Publication Details
Publication Date
2020-09-09
Journal
Publisher
ISSN
Cited by
108
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest